Pharma
THREAD Research CEO John Reites speaks on the state of remote and hybrid trials, and how COVID-19 has accelerated an already blossoming field.
The companies will be looking at the real-world data from treatment with BRAF and MEK inhibitors.
The partners will use a new method of training AI known as transformer neural networks.
The company made collaboration agreements with Empatica and etectRx, and a licensing deal with KeyWise.
Digital therapeutics startup Dthera Sciences was sunk by Alzheimer's drug failures, CMS reimbursemen
Former CEO Ed Cox tells the story of Dthera Sciences and outlines how the digital therapeutics landscape has shifted since his company's heyday.
Dr. Charlotte Jones-Burton, who leads Otsuka’s Global Clinical Development on Nephrology, discusses how COVID-19 has changed care.
Also: Dexcom promotes Jereme Sylvain to EVP and CFO; Amalgam Rx snags CMS' Jennifer Main as COO and CFO.
The pair talk about the shift from traditional clinical trials based on drug research to digital innovations.
Also: PainChek's app picks up European and Australian regulatory clearances; Digital health access as a social determinant of health.
SmileDirectClub taps NexHealth's EHR API; Digital pathology companies partner on prostate cancer detection.